Grant Lewis

Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium and Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (N08CB/Alliance)

Charles L. Loprinzi, Rui Qin, Shaker R. Dakhil et al. · Journal of Clinical Oncology · 2013 · 231 citations

Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KITD816V

Celalettin Üstün, Christopher L. Corless, Natasha M. Savage et al. · Leukemia Research · 2008 · 72 citations

Hematological Malignancy, Molecular Remission, Acute Myeloid Leukemia +10

Acute Myelogenous Leukemia Patients Are at Low Risk for Invasive Fungal Infections after High-Dose Cytarabine Consolidations and Thus Do Not Require Prophylaxis

Grant Lewis, Patricia Hall, Nihal Eisa et al. · Acta Haematologica · 2010 · 16 citations

Phase III Randomized, Placebo(Pl)-Controlled, Double-Blind Study of Intravenous Calcium/Magnesium (CaMg) to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (sNT), N08CB: an Alliance for Clinical Trials in Oncology Study1

Axel Grothey, Rui Qin, Shaker R. Dakhil et al. · Annals of Oncology · 2013 · 14 citations · Full text

Oncology Study1, Oncology, Intravenous Calcium/magnesium +9

Phase III randomized, placebo (PL)-controlled, double-blind study of intravenous calcium/magnesium (CaMg) to prevent oxaliplatin-induced sensory neurotoxicity (sNT), N08CB: An alliance for clinical trials in oncology study.

Charles L. Loprinzi, Rui Qin, Shaker R. Dakhil et al. · Journal of Clinical Oncology · 2013 · 14 citations

Pharmacotherapy, Iv Camg, Experimental Pharmacology +16